Skip to main content
Premium Trial:

Request an Annual Quote

Hyseq Pockets $15M in Private Stock Placement

NEW YORK, April 10 - Hyseq Pharmaceuticals said yesterday it has pocketed about $15 million in a private stock placement.

Investors, which included new and existing institutional investors, bought roughly 3.6 million shares of newly issued common stock at $4.20 per share.

Hyseq said it also issued warrants to the investors to buy approximately 894,000 additional shares for $5.67 apiece, or a 35 percent premium to the per-unit purchase price. 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.